Citeline Podcasts

On this week’s podcast, we discuss what in the world of interventional cardiology devices came out of TCT 2016, which just wrapped up in Washington, DC. Also, the public meeting on the US MDUFA IV user-fee agreement.

On this week's podcast, we discussed the latest details available for the proposed US device user-fee agreement, GE's next steps in mammography, a medtech perspective on the US election and details on a venture-backed firm developing drug-eluting bone scaffolds.

On this week's podcast, we discussed the latest details available for the proposed US device user-fee agreement, GE's next steps in mammography, a medtech perspective on the US election and details on a venture-backed firm developing drug-eluting bone scaffolds.

On this week's podcast, we discussed the latest details available for the proposed US device user-fee agreement, GE's next steps in mammography, a medtech perspective on the US election and details on a venture-backed firm developing drug-eluting bone scaffolds.

On this week's podcast, Ferdous Al-Faruque and Reed Miller discuss some of their takeaways from the recent AdvaMed 2016 conference. They emphasize mHealth and novel strategies for clinical data-collection as two key themes from the meeting.

On this week's podcast, Ferdous Al-Faruque and Reed Miller discuss some of their takeaways from the recent AdvaMed 2016 conference. They emphasize mHealth and novel strategies for clinical data-collection as two key themes from the meeting.

On this week's podcast, Ferdous Al-Faruque and Reed Miller discuss some of their takeaways from the recent AdvaMed 2016 conference. They emphasize mHealth and novel strategies for clinical data-collection as two key themes from the meeting.

On this week's podcast, we discussed trends and challenges with adverse-event reporting, lab-developed test marketing, some companion diagnostic data and a look ahead to this week's AdvaMed conference in Minneapolis.

On this week's podcast, we discussed trends and challenges with adverse-event reporting, lab-developed test marketing, some companion diagnostic data and a look ahead to this week's AdvaMed conference in Minneapolis.

On this week's podcast, we discussed trends and challenges with adverse-event reporting, lab-developed test marketing, some companion diagnostic data and a look ahead to this week's AdvaMed conference in Minneapolis.